About Us

Staffed with nationally recognized doctors and nurses, the Center for Pediatric Cancer and Blood Disorders at Riley Hospital for Children is dedicated to providing preeminent care for children and adolescents with cancer or blood-related diseases across Indiana and beyond.  A leading source of research and discovery, our team seeks new approaches to the prevention, diagnosis and treatment of childhood cancer and blood disorders.   

Riley Hospital for Children services the entire state of Indiana as well as bordering regions of Michigan, Illinois, Ohio, and Kentucky. With comprehensive interdisciplinary disease-focused teams, doctors and staff treat 75 percent of all new pediatric cancer diagnoses in Indiana and see an average of 300 new oncology patients each year, recording more than 13,000 outpatient visits per year focused on leukemias, solid tumors, brain tumors, hematopoietic/stem cell transplant, general hematology, sickle cell disease, bone marrow failure syndromes, hemophilia and other coagulation disorders. Moreover, Riley Hospital for Children at Indiana University Health offers the only pediatric stem cell transplant program in the state of Indiana, treating 30-40 patients per year.  All of the physicians in Pediatric Hematology/Oncology are faculty members at the IU School of Medicine. A group of highly-trained Nurse Practitioners work side by side the physician team to provide the highest level of care and a dedicated group of social workers, child life specialists and other ancillary staff focus on helping patients and families through treatment and life afterwards.  The faculty in the Center for Pediatric Cancer and Blood Disorders at Riley Hospital for Children at Indiana University School of Medicine are fully integrated as a comprehensive service line with a mission to be a world-class academic healthcare leader for children with cancer and blood disorders.

By integrating patient care and research our team aims to improve outcomes in children with cancer and blood disorders while working to continually provide the best care for all children. A longstanding member of the Children’s Oncology Group, the Section of Pediatric Hematology/Oncology provides the only local access to a variety of investigational treatments and is consistently one of the top five COG centers for clinical trial enrollment.  In addition, we have a strong foundation in precision medicine which allows doctors and researchers to optimize their approaches based on individual needs to management of pediatric cancer and blood disorders.  Our cutting-edge clinical and research programs are critical to moving this field forward to improve treatment for life-threatening cancers as well as pediatric blood disorders.   Our Precision Genomics Clinical Program currently helps children with all types of relapsed or aggressive cancer receive personalized treatment and is one of the only program of its kind in the Midwest to offer this comprehensive, personalized medicine service.



The Childhood Cancer Survivor Program at Riley Children’s Cancer Center is designed to help meet the unique needs of the growing population of childhood cancer survivors. Nearly 90 percent of children who are diagnosed with cancer today are expected to become survivors of their illness. It is now estimated that 375,000 adults are survivors of childhood cancer. Sixty percent of the children who survive their disease suffer devastating late effects and our multidisciplinary clinic provides surveillance and early intervention for these ongoing medical needs, as well as psychosocial support including education and occupational counseling.

Our outstanding program allows us to provide world class academic health care for children and young adults with cancer and blood disorders, and to improve health through innovative, quality driven, family centered care, cutting edge research and the education of current and future leaders.